Key Performance Indicators (KPIs)
These indicators are evidence-based and have been determined through extensive examination and discussion by audit governance, as well as consultation with other experts and stakeholders in the field of breast cancer treatment.
Audit participants can check their performance against these indicators at any time through the online portal. The practice value for each indicator is based on cases diagnosed between 2018 and the present day.
|BCS referred for RT||Percentage of invasive cases undergoing breast conserving surgery referred for radiotherapy||85% or more|
|ER+ for hormone therapy||Percentage of oestrogen positive invasive cases referred for hormonal therapy||85% or more|
|Axillary surgery||Percentage of invasive cases undergoing axillary surgery||90% or more|
|Node negative axillary clearance||Percentage of axillary clearance cases with zero positive nodes entered||5% or less|
|High risk with Mx for RT||Percentage of high-risk invasive cases undergoing mastectomy referred for radiotherapy||85% or more|
|High risk for CT||Percentage of high-risk cases referred for chemotherapy||90% or more|
|Use of Breast Nurse||Percentage of cases with involvement of a breast care nurse in management of the patient||90% or more|
|Participation in MDT||Percentage of cases with discussion at a multidisciplinary meeting||90% or more|
|TN and HER2+ for NACT||Percentage of Triple Negative or HER2+ cases undergoing neoadjuvant chemotherapy, for patients <70 years old and tumour size ≥20mm||70% or more|
|Immediate reconstruction (DCIS)||Percentage of in situ cases undergoing mastectomy receiving immediate reconstruction||N/A|
|Immediate reconstruction (invasive)||Percentage of invasive cases undergoing mastectomy receiving immediate reconstruction||N/A|
|BCS in T1||Percentage of cases with breast conservation for invasive T1 (<20mm)||N/A|
|Time to surgery||Percentage of cases proceeding to surgery within 45 days of histological diagnosis, e.g. date of core biopsy||N/A|
High risk definitions
High risk with Mx for RT: Invasive tumours of at least 50mm or with at least four positive lymph nodes
High risk for CT: Invasive tumours that fall into any of the following categories:
- Age less than 55 and Grade more than one and Tumour size more than two centimetres
- Age less than 55 and Grade more than one and Tumour size not more than two centimetres and Nodes involved
- Age not more than 70 and Tumour Her2 Positive and Tumour size more than five millimetres
- Age not more than 70 and Receptors Triple Negative and Tumour size more than five millimetres.